Introduction
ucormycosis is a term demonstrates a wide range of illnesses caused by infection commonly caused by Rhizopus species of fungi. In down sequence, other genera mucormycosis causing species includes Mucor, Cunninghamella, Apophysomyces, Absidia, Saksenaea, Rhizomucor, and several others. Most mucormycosis infections are extreme specially with risk factors, for example, diabetic ketoacidosis and neutropenia which are found in the majority of cases. Serious infection of the paranasal sinuses which may expand to the brain, is the widely recognized presentation 1, 2 . The infection happens following inward breath of contagious sporangiospores into the paranasal sinuses, and may then quickly extend into adjacent tissues 3 . Once the attacking fungus germinated, it will grow posteriorly to invade the sphenoid sinus, laterally to the cavernous sinus to attack the orbits, inferiorly to attack the palate, or cranially to assault the brain 4 . The fungus goes intracranialy all through either the orbital apex or ethmoid cribriform plate and this can lead to death. Occasionally, cerebral vascular invasion can lead to hematogenous distribution of the disease with or without progression of mycotic aneurysms 5 . Mucormycosis ought to be considered as a medico-surgical crisis, antifungal therapy should be prescribed at any minor suggestion of the illness. Likewise, patients should have endoscopic assessment immediately so as to survey sinonasal structures and to take appropriate samples for histopathologic and microbiologic testing. Direct nasal smear and fungal cultures are helpful in the diagnosis, although negative results does not exclude the disease. Intraoperative frozen section is a specific M and sensitive strategy for making a quick conclusion of rhinocerebral zygomycosis. Discovery of non-septate, branching (at 90 degrees) hyphae without granuloma formation in the biopsy establishes the diagnosis.
Fine-needle aspiration cytology seems to be a practical option to tissue biopsy. Computed tomography(CT) ( fig.1 ), or magnetic resonance imaging (MRI) is fundamental for staging the level of the condition as penetration of periantral fat planes may indicate the initial imaging proof of invasive fungal disease and should suggest the likelihood of invasive fungal sinusitis 6 . sufficient debridement for removal of all devitalized tissue up to healthy or bleeding borders is vital, and multiple debridements may be necessary in few patients 7 . The result of management is fine when the condition is anatomically constrained to the sinuses. In a study in India, the success rate of the treatment in stage I illness was 91% 8 . The contention for careful debridement of all influenced tissue in patients with mucormycosis, depends on the capacity of the fungus to expand along the walls and blood vessels lumen which can bring about necrotising arteritis and ischemic necrosis of the tissues prompting poor distribution of systemically administered drugs 9, 10 .
Patients and Methods
This is a prospective cross-sectional analytical study performed in the period between March 2011 to March 2016, in Basrah General Hospital. The study included all patients proved to have mucormycosis histopathologically and were admitted or referred to Basrah General Hospital. A special questionnaire form was prepared by the authors and filled by house officer doctors of the ward. Initial investigations included complete blood counts, blood urea, serum creatinine, serum glucose. Rigid nasal endoscopy and biopsy was done for all patients and suspicious tissue was sent for histopathology. Computed tomography scanning of the paranansal sinuses, orbit, and brain, including axial and coronal sections was performed in all the cases to determine the extent of the disease. Magnetic resonance imaging was performed only for 9 patients suspected to have intracranial invasions (having neurological abnormalities) but only 6 of them had real intracranial invasion. The diagnosis was made in all cases by the presence of non-septate branching hyphae on histopathologic sections. The treatment was considered according to the currently suggested methods in textbooks. Following surgery (debridement) which was performed for all patients except six (4 has cerebral invasion and 2 refuse treatment), all patients were followed closely for disease progression and repeated debridement was done when necessary. The immunological status of patients with mucormycosis is shown in figure 3 , it is found that the majority of the studied patients (27 out of total 32, 84.4%) were immuno-compromised, while the remaining 5 (15.6%) patients were immuno-competent. The majority of immuno-compromised patients were diabetics 14 (51.9%), followed by renal failure in which 8 patients (29.6%) were reported, 3 were leukemic children and 2 patients were affected by lymphomas, one child had renal cell carcinoma for which cytotoxic drugs were given and 4 patients had multiple risk factors as demonstrated in figure 4.
Results

This
Figure 4: Risk factors for patients with mucormycosis
The distribution of symptoms and signs is illustrated in table II, it was found that the most frequent symptoms were facial pain and numbness (27, 84.3%), followed by headache (20, 62.5%), nasal obstruction and anosmia (20, 62.5%), while the most frequent sign was nasal obstruction and eshcar (28, 87.5%). 
Discussion
Rhino-orbito-cerebral (ROC) mucormycosis is generally uncommon disease 11 . The reasonable frequently diagnosed ROC mucormycosis in our community is most likely because of poor health care standard with low socioeconomic and educational levels. In the present study, males are more affected than females, the proportion was 2.2:1, probably in light of the fact that hazard factors were more typical in males in addition they have more exposure to infective organisms due to outdoor work. The mostly affected age group by ROC mucormycosis in this study was 51-60 years(50%). Three kids have the disease in this series (9%) (figure 5). The significant thing is that 5 out of 32 patents were immunocompetent, that raise the reality that ROC mucormycosis not just influence those with high risk. Invasive fungal diseases recently have been accounted to be increasing in immunocompetent patients. Environmental and local variables may influence normal hosts and increases patient's hazard for having fungal paranasal sinus infections, including repetitive contact to food or air which is contaminated with mycotic spores. Root canal fillings, exposure to residential pets, chronic or recurrent bacterial sinusitis, and a long-standing use of wide-spectrum antibiotics or topical steroid use are also threat factors 11 . The most widely recognized risk factor in this study is uncontrolled DM which constitutes 44.4% of the cases (figure 6), this runs with many authors [12] [13] [14] . As indicated by many investigations, the most essential conditions make patients susceptible to mucormycosis, comprise malignant blood disease with or without stem cell transplantation, uncontrolled diabetes mellitus with or without diabetic ketoacidosis, long time and serious neutropenia, overload of iron, significant trauma, prolonged use of corticosteroids, illegal intravenous drug use, neonatal prematurity and malnourishment 15 . Apart from host-related risk factors, bad hospital environment may be responsible. Nosocomial mucormycosis has been related to contact air loaded with fungus because of building work, unhygienic air filters, or a variety of healthcare-related methods and equipments such as nonsterilized dressings of the wound, transdermal nitrate patches, intravenous catheters, tongue depressors or allopurinol pills 16 . Minimal iatrogenic outbreaks have been occurred 17, 18 . In 36%-88% of the patients, diabetes mellitus is the primary predisposing reason for mucormycosis [19] [20] [21] , the most vulnerable are those with ketoacidosis 22, 23 . Various patients with undiscovered or uncontrolled diabetes, mucormycosis is the first incident 24 . In fact, type1, type2, and secondary diabetes mellitus are hazard factors for mucormycosis 25 . The epidemiology of mucormycosis in diabetic cases is rising, Roden et al 15 found that diabetes includes 36% of 929 reported cases, yet there was a diminished recurrence of mucormycosis in diabetics with time. Nevertheless, mucormycosis remains an frightening hazard in diabetics 26 . A comprehensive retrospective study in France showed 9% annual increase in incidence of mucormycosis in diabetics 27 . In India, a study exhibited that 74% of cases with mucormycosis had uncontrolled diabetes; in 43% of them, diabetes was diagnosed for the first time 28 . The frequently reported symptoms in the present investigation are; facial agony, numbness, headache, nasal discharge and anosmia, and the most widely recognized signs were; nasal crustation, eshcar and facial edema. These results goes with Spellberg and Talmi studies 13, 29 . The initial symptoms of ROC mucormycosis runs with those of sinusitis and periorbital cellulitis and include eye and or facial pain with numbness followed by visual impairment 3 . Clinical features that suggest mucormycosis in vulnerable individuals includes; headache, multiple cranial nerve palsies, orbital inflammation, eyelid edema, oneside periorbital facial pain, proptosis, ptosis, ophthalmoplegia, acute ocular motility changes, and acute loss of vision. Conclusion; Index of suspicion by general practitioner, physician, and ENT house officer is very necessary in diagnosis of RCO mucormycosis. The disease can affect even immunocompetent persons, and early diagnosis by histopathological assessment of necrotic tissue is very supportive for earlier start of management.
A dark necrotic eschar is a trademark feature of mucormycosis(figure 7), but the absence of this finding does not exclude the likelihood of mucormycosis. Fever is conflicting and may not present in up to half of cases. The white blood cell count is classically high as long as the patient has working bone marrow 30 .
